INO

Q: What is the price of Inovio Pharmaceuticals (INO) today?

The current price of Inovio Pharmaceuticals (INO) is $ 1.10, representing a -45% gain over the past year. The stock began the year trading around $ 1.74 and is currently priced at $ 1.10. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Inovio Pharmaceuticals (INO) pay dividends?

Inovio Pharmaceuticals (INO) did not pay dividends over the past year.

Inovio Pharmaceuticals Inc.

Price

$ 1.10

return (12m)

-45.00%

p/e

-0.89

p/bv

12.50

DIVIDEND YIELD

0.00%

INO price

Inovio Pharmaceuticals

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment INO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-15.38%

3 months

-34.52%

1 year

-45.00%

2 years

-87.90%

5 years

-98.96%

10 years

-99.16%

Fundamentals INO

review the fundamentals of Inovio Pharmaceuticals shares

P/E

-0.89

Sector: -3.80 Industry: -3.80

P/S (PSR)

Sector: -4.18 Industry: -4.18

P/BV

12.50

Sector: 1.92 Industry: 1.92

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-170.61%

Sector: -65.32% Industry: -65.32%

ROE

-1,399.18%

Sector: -66.07% Industry: -66.07%

ROIC

-181.72%

Sector: -2,920.39% Industry: -2,920.39%

NET MARGIN

0.00%

Sector: -40.34% Industry: -40.34%

GROSS MARGIN

0.00%

Sector: 36.85% Industry: 36.85%

OPERATING MARGIN

0.00%

Sector: -39.20% Industry: -39.20%

EV/EBITDA

-0.90

Sector: -3.89 Industry: -3.89

EV/EBIT

-0.87

Sector: -3.98 Industry: -3.98

PRICE-TO-ASSETS

1.52

Sector: 1.42 Industry: 1.42

BVPS

0.09

Sector: 1.86 Industry: 1.86

EPS

-1.23

Sector: -2.12 Industry: -2.12

EQUITY-TO-ASSETS RATIO

0.12

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.88

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-22.49%

Sector: - Industry: -

Fundamentals INO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	27.58	7.15	25.92%	2.18%	$ 580.26 B	21.83%
PFE	19.91	1.65	8.29%	6.56%	$ 149.16 B	11.83%
ABBV	110.89	-60.96	-54.98%	2.96%	$ 403.08 B	5.79%
NVO	65.46	40.20	61.41%	4.25%	$ 195.21 B	37.07%
MRK	32.94	6.41	19.45%	2.79%	$ 294.29 B	13.59%
AZN	26.65	5.84	21.93%	1.79%	$ 276.88 B	17.19%
GILD	16.93	6.66	39.33%	2.54%	$ 155.98 B	30.99%
BMY	16.00	5.79	36.19%	4.38%	$ 116.43 B	15.01%
ZTS	12.70	10.39	81.75%	2.59%	$ 33.58 B	27.79%
REGN	14.39	2.03	14.08%	0.59%	$ 63.66 B	29.65%
HALO	23.51	37.34	158.82%	0.00%	$ 8.20 B	23.13%
AMGN	24.59	20.87	84.87%	2.76%	$ 191.81 B	20.96%
MCK	20.09	-114.69	-570.98%	0.40%	$ 95.65 B	1.18%
HRMY	13.72	2.20	16.00%	0.00%	$ 2.00 B	16.20%
VRTX	26.05	5.84	22.41%	0.00%	$ 113.01 B	35.51%
CAH	33.83	-19.69	-58.20%	0.91%	$ 52.60 B	0.62%
ADMA	11.72	4.96	42.37%	0.00%	$ 1.94 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

INO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/27/2017	10/16/2017	0,82800000
Dividends	08/29/2017	09/15/2017	0,82800000

ABOUT Inovio Pharmaceuticals

Inovio Pharmaceuticals Inc.

Average Investor10 user rating

5.0 (3 people)

United States

43 years

Founded: 1983

1998

Time since IPO - 28 years

190

Employees

Inovio Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $75.90 Millions, with shareholders equity totaling $6.07 Millions.

The company employs approximately 190 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Inovio Pharmaceuticals Inc. reported $- in revenue, generating net income of $-84.93 Millions.

Key financial metrics include a P/E ratio of -0.89, a price-to-book (P/B) ratio of 12.50, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker INO.

Market cap

$ 75.90 Millions

Net worth

$ 6.07 Millions

$ 6,070,000.00

Assets

$ 49.78 Millions

$ 49,780,000.00

Total Shares Outstanding

69.00 Millions

69,000,000

Average Daily Trading Volume

$ 3.21 Millions

$ 3,207,704.00

Sector

Health Care

Industry

Biotechnology

INO

INO revenue and profits

Financial Results INO

DRAG THE FRAME TO SEE MORE DATA

INO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 779.78 8,92% (12M)

P/E

20.09

0.40%

ROE

-570.98%

P/BV

-114.69

CAH - Cardinal Health

$ 226.40 41,32% (12M)

P/E

33.83

0.91%

ROE

-58.20%

P/BV

-19.69

JNJ - Johnson & Johnson

$ 235.66 55,63% (12M)

P/E

27.58

2.18%

ROE

25.92%

P/BV

7.15

MRK - Merck & Co.

$ 114.90 48,09% (12M)

P/E

32.94

2.79%

ROE

19.45%

P/BV

6.41

AZN - AstraZeneca

$ 177.27 27,08% (12M)

P/E

26.65

1.79%

ROE

21.93%

P/BV

5.84

ABBV - AbbVie

$ 221.59 19,79% (12M)

P/E

110.89

2.96%

ROE

-54.98%

P/BV

-60.96

PFE - Pfizer

$ 26.00 14,03% (12M)

P/E

19.91

6.56%

ROE

8.29%

P/BV

1.65

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 779.78 8,92% (12 M)

P/L

20.09

0.40%

ROE

-570.98%

P/VP

-114.69

CAH - Cardinal Health

$ 226.40 41,32% (12 M)

P/L

33.83

0.91%

ROE

-58.20%

P/VP

-19.69

JNJ - Johnson & Johnson

$ 235.66 55,63% (12 M)

P/L

27.58

2.18%

ROE

25.92%

P/VP

7.15

MRK - Merck & Co.

$ 114.90 48,09% (12 M)

P/L

32.94

2.79%

ROE

19.45%

P/VP

6.41

AZN - AstraZeneca

$ 177.27 27,08% (12 M)

P/L

26.65

1.79%

ROE

21.93%

P/VP

5.84

ABBV - AbbVie

$ 221.59 19,79% (12 M)

P/L

110.89

2.96%

ROE

-54.98%

P/VP

-60.96

PFE - Pfizer

$ 26.00 14,03% (12 M)

P/L

19.91

6.56%

ROE

8.29%

P/VP

1.65

Frequently Asked Questions

What is the price of Inovio Pharmaceuticals (INO) today?

The current price of Inovio Pharmaceuticals (INO) is $ 1.10, representing a -45% gain over the past year. The stock began the year trading around $ 1.74 and is currently priced at $ 1.10. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Inovio Pharmaceuticals (INO) pay dividends?

Inovio Pharmaceuticals (INO) did not pay dividends over the past year.

Is Inovio Pharmaceuticals (INO) a good investment?

Inovio Pharmaceuticals (INO) is currently trading at $ 1.10 with a P/E ratio of -0.89. This represents a -102% premium compared to its historical average P/E. Over the past year, the stock has gained -45 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -45.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Inovio Pharmaceuticals (INO) stock?

You can buy Inovio Pharmaceuticals (INO) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol INO and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Inovio Pharmaceuticals (INO) yield today?

Over the past month, Inovio Pharmaceuticals (INO) has returned -15.38% — -45.00% over the past year, and -98.96% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Inovio Pharmaceuticals (INO) today at the current price of $ 1.10 your total investment would be $ 110.00.

Based on historical performance, the investment would have grown to approximately:

$ 60.50 after 1 year
$ 1.14 after 5 years
$ 0.92 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

INO

Inovio Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment INO

review the fundamentals of Inovio Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Inovio Pharmaceuticals

Inovio Pharmaceuticals Inc.

United States

43 years

1998

190

PROFIT X PRICE INO

Financial Results INO

INO cash flow

Asset, Revenue and Profit Growth - INO

INO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

Frequently Asked Questions